Implementation of smart technology to improve medication adherence in patients with cardiovascular disease: is it effective?

References

• Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–2619.
   PubMed Web of Science ®Google Scholar
• ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345:669–685.
   PubMed Web of Science ®Google Scholar
• Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–1278.
   PubMed Web of Science ®Google Scholar
• MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126–1131.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;2016(37):2129–2200.
   Web of Science ®Google Scholar
• Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349:1019–1026.
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez JA, Sterne JAC, Thom HHZ, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. Bmj. 2017;359:j5058.
   PubMedGoogle Scholar
• Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377:1319–1330.
   PubMed Web of Science ®Google Scholar
• Randomised trial of cholesterol lowering in. 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.
   PubMed Web of Science ®Google Scholar
• Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301–1307.
   PubMed Web of Science ®Google Scholar
• Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med. 1996;335:1001–1009.
   PubMed Web of Science ®Google Scholar
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349–1357.
   Google Scholar
• Serruys PW, De Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. Jama. 2002;287:3215–3222.
   PubMed Web of Science ®Google Scholar
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in. 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22.
   PubMed Web of Science ®Google Scholar
• Perk J, De BG, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–1701.
   PubMed Web of Science ®Google Scholar
• Bosworth HB, Powers BJ, Olsen MK, et al. Home blood pressure management and improved blood pressure control results from a randomized controlled trial. Archives of Internal Medicine. 2011;171:1173–1180.
   PubMedGoogle Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772–779.
   PubMed Web of Science ®Google Scholar
• Piazza G, Karipineni N, Goldberg HS, et al. Underutilization of anticoagulation for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2016;67:2444–2446.
   PubMed Web of Science ®Google Scholar
• Reilly PA, Lehr T, Haertter S, et al. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY trial (randomized evaluation of long-term anticoagulation therapy). J Am Coll Cardiol. 2014;63:321–328.
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. Bmj. 2006;333:15.
   PubMed Web of Science ®Google Scholar
• Treskes RW, Van Der Velde ET, Atsma DE, et al. Redesigning healthcare: the 2.4 billion euro question? Connecting smart technology to improve outcome of patients. Neth Heart J. 2016.
   PubMed Web of Science ®Google Scholar
• Treskes RW, Van Der Velde ET, Barendse R, et al. Mobile health in cardiology: a review of currently available medical apps and equipment for remote monitoring. Expert Rev Med Devices. 2016;13:823–830.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Bax J, Bruining N, et al. e-Health: a position statement of the European Society of Cardiology. Eur Heart J. 2016;37:63–66.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Sipido KR, Cowie MR, et al. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J. 2014;35:3250–3257.
   PubMed Web of Science ®Google Scholar
• Checchi KD, Huybrechts KF, Avorn J, et al. Electronic medication packaging devices and medication adherence: a systematic review. Jama. 2014;312:1237–1247.
   PubMed Web of Science ®Google Scholar
• Griffiths F, Lindenmeyer A, Powell J, et al. Why are health care interventions delivered over the internet? A systematic review of the published literature. J Med Internet Res. 2006;8:e10
   Google Scholar
• Number of available apps in the Apple App Store from July 2008 to January 2017. [ cited 2017 October 30th]. Available from: https://www.statista.com/statistics/263795/number-of-available-apps-in-the-apple-app-store/].
   Google Scholar
• New report finds more than 165,000 mobile health apps now available, takes close look at characteristics & use 2017 [ cited 2017 October 30th]. Available from: https://www.imedicalapps.com/2015/09/ims-health-apps-report/].
   Google Scholar
• Johnston N, Bodegard J, Jerstrom S, et al. Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: a randomized study. Am Heart J. 2016;178:85–94.
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Y, Da L, et al. Mobile health technology for atrial fibrillation management integrating decision support, education, and patient involvement: mAF app trial. Am J Med. 2017;130:1388–1396.
   PubMed Web of Science ®Google Scholar
• Labovitz DL, Shafner L, Reyes GM, et al. Using artificial intelligence to reduce the risk of nonadherence in patients on anticoagulation therapy. Stroke. 2017;48:1416–1419.
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Intern Med. 2017;177:624–631.
   PubMed Web of Science ®Google Scholar
• Volpp KG, Troxel AB, Mehta SJ, et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction: the heartstrong randomized clinical trial. JAMA Intern Med. 2017;177:1093–1101.
   PubMed Web of Science ®Google Scholar
• Kooy MJ, Van Wijk BL, Heerdink ER, et al. Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Front Pharmacol. 2013;4:69.
   PubMed Web of Science ®Google Scholar
• Brath H, Morak J, Kastenbauer T, et al. Mobile health (mHealth) based medication adherence measurement - a pilot trial using electronic blisters in diabetes patients. Br J Clin Pharmacol. 2013;76(Suppl 1):47–55.
   PubMed Web of Science ®Google Scholar
• McKenney JM, Munroe WP, Wright JT Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol. 1992;32:277–283.
   PubMed Web of Science ®Google Scholar
• SMS 2017 [cited 2017 Oct 18th]. Available from: https://en.wikipedia.org/wiki/SMS].
   Google Scholar
• Kamal AK, Shaikh Q, Pasha O, et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study. BMC Neurol. 2015;15:212.
   PubMed Web of Science ®Google Scholar
• Maslakpak MH, Safaie M. A comparison between the effectiveness of short message service and reminder cards regarding medication adherence in patients with hypertension: a randomized controlled clinical trial. Int J Commun Based Nurs Midwifery. 2016;4:209–218.
   PubMedGoogle Scholar
• Akhu-Zaheya LM, Shiyab WY. The effect of short message system (SMS) reminder on adherence to a healthy diet, medication, and cessation of smoking among adult patients with cardiovascular diseases. Int J Med Inform. 2017;98:65–75.
   PubMed Web of Science ®Google Scholar
• Fang R, Li X. Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. J Clin Nurs. 2016;25:664–671.
   PubMed Web of Science ®Google Scholar
• Quilici J, Fugon L, Beguin S, et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. Int J Cardiol. 2013;168:568–569.
   PubMed Web of Science ®Google Scholar
• Khonsari S, Subramanian P, Chinna K, et al. Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. Eur J Cardiovasc Nurs. 2015;14:170–179.
   PubMed Web of Science ®Google Scholar
• Wald DS, Bestwick JP, Raiman L, et al. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS One. 2014;9:e114268.
   PubMed Web of Science ®Google Scholar
• Bobrow K, Farmer AJ, Springer D, et al. Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-Text Adherence Support [StAR]): a single-blind, randomized trial. Circulation. 2016;133:592–600.
   PubMed Web of Science ®Google Scholar
• Park LG, Howie-Esquivel J, Whooley MA, et al. Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. Eur J Cardiovasc Nurs. 2015;14:264–273.
   PubMed Web of Science ®Google Scholar
• Huber D, Henriksson R, Jakobsson S, et al. Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: one-year results from the randomized controlled NAILED-ACS trial. PLoS One. 2017;12:e0183963.
   PubMedGoogle Scholar
• Bosworth HB, Olsen MK, Grubber JM, et al. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med. 2009;151:687–695.
   PubMed Web of Science ®Google Scholar
• Yu M, Chair SY, Chan CW, et al. A health education booklet and telephone follow-ups can improve medication adherence, health-related quality of life, and psychological status of patients with heart failure. Heart Lung. 2015;44:400–407.
   PubMed Web of Science ®Google Scholar
• Hedegaard U, Kjeldsen LJ, Pottegard A, et al. Improving medication adherence in patients with hypertension: a randomized trial. Am J Med. 2015;128:1351–1361.
   PubMed Web of Science ®Google Scholar
• Salvo MC, Cannon-Breland ML. Motivational interviewing for medication adherence. J Am Pharm Assoc. 2003–2015;55: e354–61. quiz e62–3.
   Google Scholar
• Fischer MA, Choudhry NK, Bykov K, et al. Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications. Med Care. 2014;52:1050–1054.
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Owen-Smith AA, Tom JO, et al. Improving adherence to cardiovascular disease medications with information technology. Am J Manag Care. 2014;20:SP502–SP10.
   PubMed Web of Science ®Google Scholar
• Percentage of households with personal computers in 2014. [ cited 2017 October 18th]. Available from: https://www.statista.com/statistics/551760/worldwide-selected-countries-personal-computers-as-percentage-households/].
   Google Scholar
• Lussier MT, Richard C, Glaser E, et al. The impact of a primary care e-communication intervention on the participation of chronic disease patients who had not reached guideline suggested treatment goals. Patient Educ Couns. 2016;99:530–541.
   PubMed Web of Science ®Google Scholar
• Keyserling TC, Sheridan SL, Draeger LB, et al. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Intern Med. 2014;174:1144–1157.
   PubMed Web of Science ®Google Scholar
• Martin MY, Kim YI, Kratt P, et al. Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based intervention. Am J Health Promot. 2011;25:372–378.
   PubMed Web of Science ®Google Scholar
• Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.
   PubMed Web of Science ®Google Scholar
• Greene J, Hibbard J. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27:520–526.
   PubMed Web of Science ®Google Scholar
• Wikipedia. Machine learning; 2017; [cited 2017 Oct 18th]. Available from: https://en.wikipedia.org/wiki/Machine_learning].
   Google Scholar